Show simple item record

dc.contributor.authorde Teresa, Eduardo
dc.contributor.authorNavarro-López, Francisco
dc.contributor.authorNavarro, Xavier
dc.contributor.authorStockburger, Martin
dc.contributor.authorGómez-Doblas, Juan José
dc.contributor.authorLamas, Gervasio
dc.contributor.authorAlzueta, Javier
dc.contributor.authorFernández-Lozano, Ignacio
dc.contributor.authorCobo Valeri, Erik
dc.contributor.authorWiegand, Uwe
dc.contributor.authorFernández de la Concha, Joaquín
dc.contributor.otherUniversitat Politècnica de Catalunya. Departament d'Estadística i Investigació Operativa
dc.identifier.citationStockburger, M. [et al.]. Preventing ventricular dysfuction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF). "European journal of heart failure", Juny 2011, vol. 13, núm. 6, p. 633-641.
dc.description.abstractAims Previous experimental and clinical studies have consistently suggested that right ventricular (RV) apical pacing has important adverse effects. Ventricular pacing (VP), however, is required, and cannot be reduced in many patients with atrioventricular (AV) block. The PREVENT-HF study was an international randomized trial that explored differences in left ventricular (LV) remodelling during RV apical vs. biventricular (BIV) pacing in patients with AV block. Methods and Results Patients with an expected VP prevalence ≥80% were assigned to RV apical or BIV pacing. The primary endpoint was the change in LV end-diastolic volume (EDV) >12 months. Secondary endpoints were LV end-systolic volume (ESV), LV ejection fraction (EF), mitral regurgitation (MR), and a combination of heart failure (HF) events and cardiovascular hospitalizations. Overall, 108 patients were randomized (RV: 58; BIV: 50). Intention to treat and on-treatment analyses revealed no significant differences in any of the outcomes. Analysis of covariance (ANCOVA) difference for treatment according to randomization (in mL): LVEDV −3.92 (−18.71 to 10.85), P= 0.6; LVESV −1.38 (−12.07 to 9.31), P= 0.80; LVEF 2.47 (−3.00 to 7.94), P= 0.37. Analysis of covariance difference for the on-treatment analysis: LVEDV −4.90 (−20.02 to 10.22, PP= 0.52; LVESV −6.45 (−17.28 to 4.38), P= 0.24, LVEF 2.18 (−3.37 to 7.73), P= 0.44. Furthermore, secondary endpoints did not differ significantly. Conclusion This study did not demonstrate significant LV volume differences >12 months between RV apical and BIV pacing for AV block. Thus, BIV pacing cannot be recommended as a routine treatment for AV block in these patients. However, the results encourage and inform the design of subsequent larger trials with higher power for detecting small volume changes. Identifier: NCT00170326.
dc.format.extent9 p.
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Spain
dc.subjectÀrees temàtiques de la UPC::Matemàtiques i estadística::Estadística aplicada::Estadística biosanitària
dc.subject.lcshSampling (Statistics)
dc.titlePreventing ventricular dysfuction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF)
dc.subject.lemacMostreig (Estadística)
dc.contributor.groupUniversitat Politècnica de Catalunya. GREMA - Grup de Recerca en Estadística Matemàtica i les seves Aplicacions
dc.description.peerreviewedPeer Reviewed
dc.subject.ams62D05 Sampling theory, sample surveys
dc.rights.accessOpen Access
dc.description.versionPostprint (published version)
local.citation.authorStockburger, M.; Gómez-Doblas, J.; Lamas, G.; Alzueta, J.; Fernández-Lozano, I.; Cobo, E.; Wiegand, U.; Fernández de la Concha, J.; Navarro, X.; Navarro-López, F.; de Teresa, E.
local.citation.publicationNameEuropean journal of heart failure

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Spain
Except where otherwise noted, content on this work is licensed under a Creative Commons license : Attribution-NonCommercial-NoDerivs 3.0 Spain